Ankrd50 | ankyrin repeat domain 50
Physiological systems
4 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Behavior/neurological Mortality/aging
2 No significant impact
20 Not tested
Data collections
Gene metrics:3Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| hyperactivity | 1 supporting dataset | Ankrd50em1(IMPC)Bay | homozygote | Early adult | 6.27x10-5 | ||
| increased vertical activity | 1 supporting dataset | Ankrd50em1(IMPC)Bay | homozygote | Early adult | 3.26x10-6 | ||
| preweaning lethality, incomplete penetrance | 1 supporting dataset | Ankrd50em1(IMPC)Bay | homozygote | Early adult | N/A * |
| | | | | | | | | | |
Human diseases caused by Ankrd50 mutations
The analysis uses data from IMPC, along with published data on other mouse mutants, in comparison to human disease reports in OMIM, Orphanet, and DECIPHER.
Phenotype comparisons summarize the similarity of mouse phenotypes with human disease phenotypes.
External links
No external links available for Ankrd50.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| Ankrd50em1(IMPC)Bay | Inter-exon deletion | | mouse |
| Ankrd50tm44909(L1L2_Bact_P) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |